See All Slides - tctmd.com

Slides

Presentation TCT 2013

IA Treatment: Where Do We Stand Now? Including Analysis of Recent Negative Trials

Presenter: Philip Meyers

October 31, 2013

Presentation TCT 2013

Interventional Management of Cardiogenic Stroke

Presenter: Robert Sommer

October 31, 2013

Presentation TCT 2013

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

Presenter: H. Robert Superko

October 31, 2013

Presentation TCT 2013

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Presenter: Jonathan Halperin

October 31, 2013

Presentation TCT 2013

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Presenter: Eugenia Nikolsky

October 31, 2013

Presentation TCT 2013

Overview of Paravalvular Leak Closure and Outcomes

Presenter: Chet Rihal

October 31, 2013

Presentation TCT 2013

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Presenter: James Devlin

October 31, 2013

Presentation TCT 2013

Case #3: Left Main + Ostial LAD (Medina 1,1,0)

Presenter: Jeffrey Moses

October 31, 2013

Presentation TCT 2013

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

Presenter: Nils Johnson

October 31, 2013

Presentation TCT 2013

After the TASTE Trial: Making the Case for the Routine Use of "Simple" Thrombus Aspiration!

Presenter: Giuseppe De Luca

October 31, 2013

Advertisement

Slides

IA Treatment: Where Do We Stand Now? Including Analysis of Recent Negative Trials

Interventional Management of Cardiogenic Stroke

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Outcomes of Patients Treated with Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (From the Harmonizing...

Overview of Paravalvular Leak Closure and Outcomes

Genetic Testing for 9p21 can Cost Effectively Reduce Cardiovascular Events

Case #3: Left Main + Ostial LAD (Medina 1,1,0)

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

After the TASTE Trial: Making the Case for the Routine Use of "Simple" Thrombus Aspiration!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content